Premium
FLG mutation p.Lys4021X in the C‐terminal imperfect filaggrin repeat in Japanese patients with atopic eczema
Author(s) -
NemotoHasebe I.,
Akiyama M.,
Nomura T.,
Sandilands A.,
McLean W.H.I.,
Shimizu H.
Publication year - 2009
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/j.1365-2133.2009.09406.x
Subject(s) - filaggrin , nonsense mutation , mutation , population , nonsense , genetics , biology , microbiology and biotechnology , medicine , atopic dermatitis , gene , immunology , missense mutation , environmental health
Summary Background Mutations in the gene encoding filaggrin ( FLG ) have been shown to predispose to atopic eczema (AE). Objectives Further to establish population genetics of FLG mutations in the Japanese population and to elucidate effects of FLG mutations to filaggrin biosynthesis in skin of patients with AE. Methods We searched for FLG mutations in 19 newly recruited Japanese patients with AE. We then screened 137 Japanese patients with AE and 134 Japanese control individuals for a novel mutation identified in the present study. In addition, we evaluated FLG mRNA expression by real‐time reverse transcription–polymerase chain reaction and profilaggrin/filaggrin protein expression by immunohistochemical staining in the epidermis of the patients carrying the novel mutation. Results We identified a novel FLG nonsense mutation c.12069A>T (p.Lys4021X) in one patient with AE. Upon further screening, p.Lys4021X was identified in four patients with AE (2·9% of all the patients with AE). In total, there are at least eight FLG variants in the Japanese population. Here we show that about 27% of patients in our Japanese AE case series carry one or more of these eight FLG mutations and these variants are also carried by 3·7% of Japanese general control individuals. There is a significant statistical association between the eight FLG mutations and AE (χ 2 P = 6·50 × 10 −8 ). Interestingly, the present nonsense mutation is in the C‐terminal incomplete filaggrin repeat and is the mutation nearest the C‐terminal among previously reported FLG mutations. Immunohistochemical staining for filaggrin revealed that this nonsense mutation leads to remarkable reduction of filaggrin protein expression in the patients’ epidermis. Conclusions We clearly demonstrated that FLG mutations are significantly associated with AE in the Japanese population. The present results further support the hypothesis that the C‐terminal region is essential for proper processing of profilaggrin to filaggrin.